2070009-67-3
Chemical Structure
Paricalcitol-d6
- CAS No.: 2070009-67-3
- Formula:C27H38D6O3
- Molecular Weight:422.67
IUPAC Name: (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5-methyl-6-(methyl-d3)hept-3-en-2-yl-7,7,7-d3)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
InChIKey: BPKAHTKRCLCHEA-OYAGBYDGSA-N
SMILES: C[C@]([C@@H]([C@@H](/C=C/[C@@H](C(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)C)C)CC1)(CCC/2)[C@@]1(C2=C\C=C3C[C@H](C[C@@H](C/3)O)O)[H]
Biological Activity: Paricalcitol-d6 is the deuterium labeled Paricalcitol. Paricalcitol is a agent used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Paricalcitol-d6 | 99.85% | Paricalcitol-d6 is the deuterium labeled Paricalcitol. Paricalcitol is a agent used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paricalcitol (Standard) | ≥98% | Paricalcitol (Standard) is the analytical standard of Paricalcitol. This product is intended for research and analytical applications. Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paricalcitol | 99.96% | Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
